Ruta Aldonyte

Dr. Ruta Aldonyte

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
JRJovile Raudoniute
Jovile Raudoniute
ISInga Stasiulaitiene
Inga Stasiulaitiene
IKIeva Kulvinskiene
Ieva Kulvinskiene
EBEdvardas Bagdonas
Edvardas Bagdonas
AGAndrius Garbaras
Andrius Garbaras
RARuta Aldonyte
Ruta Aldonyte

27 April 2024 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
AKAleksandras Konovalovas
Aleksandras Konovalovas
JAJulija Armalyte
Julija Armalyte
LKLaurita Klimkaitė
Laurita Klimkaitė
TLTomas Liveikis
Tomas Liveikis
BJBrigita Jonaitytė
Brigita Jonaitytė
RARuta Aldonyte
Ruta Aldonyte
Background: An increasing number of studies investigate various human microbiotas and their roles in the development of diseases, maintenance of health states, and balanced signaling towards the brain. Current data demonstrate that the nasal microbiota contains a unique and highly variable array of commensal bacteria and opportunistic pathogens. However, we need to understand how to harness current knowledge, enrich nasal microbiota with beneficial microorganisms, and prevent pathogenic developments. Results: In this study, we have obtained nasal, nasopharyngeal, and bronchoalveolar lavage fluid samples from healthy volunteers and patients suffering from chronic respiratory tract diseases for full-length 16 S rRNA sequencing analysis using Oxford Nanopore Technologies. Demographic and clinical data were collected simultaneously. The microbiome analysis of 97 people from Lithuania suffering from chronic inflammatory respiratory tract disease and healthy volunteers revealed that the human nasal microbiome represents the microbiome of the upper airways well. Conclusions: The nasal microbiota of patients was enriched with opportunistic pathogens, which could be used as indicators of respiratory tract conditions. In addition, we observed that a healthy human nasal microbiome contained several plant- and bee-associated species, suggesting the possibility of enriching human nasal microbiota via such exposures when needed. These candidate probiotics should be investigated for their modulating effects on airway and lung epithelia, immunogenic properties, neurotransmitter content, and roles in maintaining respiratory health and nose-brain interrelationships.

1 June 2023 in Future Microbiology
Verified
Journal Article
Closed access
LKLaurita Klimkaite
Laurita Klimkaite
TLTomas Liveikis
Tomas Liveikis
GKGreta Kaspute
Greta Kaspute
JAJulija Armalyte
Julija Armalyte
RARuta Aldonyte
Ruta Aldonyte
Publications addressing air pollution-induced human respiratory microbiome shifts are reviewed in this article. The healthy respiratory microbiota is characterized by a low density of bacteria, fun... Plain language summary The community of bacteria, viruses and fungi in the human body, known as the microbiome, plays an important role in human health. These communities vary in different location...

4 April 2025 in Environmental Pollution
Verified
Journal Article
Closed access
AVAgnė Vailionytė
Agnė Vailionytė
IUIeva Uogintė
Ieva Uogintė
JPJustina Pajarskienė
Justina Pajarskienė
EBEdvardas Bagdonas
Edvardas Bagdonas
TJTadas Jelinskas
Tadas Jelinskas
RARuta Aldonyte
Ruta Aldonyte

22 January 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
DGDovilė Grauzdytė
Dovilė Grauzdytė
JRJovilė Raudoniūtė
Jovilė Raudoniūtė
IKIeva Kulvinskienė
Ieva Kulvinskienė
EBEdvardas Bagdonas
Edvardas Bagdonas
ISInga Stasiulaitiene
Inga Stasiulaitiene
Petras VENSKUTONISPetras VENSKUTONIS
Petras VENSKUTONIS
According to World Health Organisation (WHO) air pollution increases the risk of cardiovascular disorders, respiratory diseases, including COPD, lung cancer and acute respiratory infections, neuro-degenerative and other diseases. It is also known that various phytochemicals may mitigate such risks. This study tested if phytochemicals mangiferin (MNG) and Z-ligustilide (Z-LG) may protect PAH-exposed human lung bronchial epithelial cells (BEAS-2B). Organic PAH extract was obtained from the urban fine PM with high benzo(a)pyrene content collected in Eastern European mid-sized city during winter heating season. Cell proliferation traits and levels of intracellular oxidative stress were examined. Effect of MNG (0.5 µg/mL) alone or in combination with PAH on bronchial epithelium wound healing was evaluated. Both phytochemicals were also evaluated for their antioxidant properties in acellular system. Treatment with MNG produced strong cytoprotective effect on PAH-exposed cells (p < 0.01) while Z-LG (0.5 µg/mL) exhibited strong negative effect on cell proliferation in untreated and PAH-exposed cells (p < 0.001). MNG, being many times stronger antioxidant than Z-LG in chemical in vitro assays (p < 0.0001), was also able to decrease PAH-induced oxidative stress in the cell cultures (p < 0.05). Consequently MNG ameliorates oxidative stress, speeds up wound healing process and restores proliferation rate in PAH-exposed bronchial epithelium. Such protective effects of MNG in air pollution affected airway epithelium stimulate further research on this promising phytochemical.

5 December 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
AKAleksandras Konovalovas
Aleksandras Konovalovas
JAJulija Armalytė
Julija Armalytė
LKLaurita Klimkaitė
Laurita Klimkaitė
TLTomas Liveikis
Tomas Liveikis
BJBrigita Jonaitytė
Brigita Jonaitytė
RARuta Aldonyte
Ruta Aldonyte
The human microbiomes, including the ones present in the respiratory tract, are described and characterized in an increasing number of studies. However, the composition and the impact of the healthy and/or impaired microbiome on pulmonary health and its interaction with the host tissues remain enigmatic. In chronic airway diseases, bronchiectasis stands out as a progressive condition characterized by microbial colonization and infection. In this study, we aimed to investigate the microbiome of the lower airways and lungs of bronchiectasis patients together with their serum cytokine and chemokine content, and gain novel insights into the pathogenesis of bronchiectasis. The microbiome of 47 patients was analyzed by sequencing of full-length 16S rRNA gene using amplicon sequencing Oxford Nanopore technologies. Their serum inflammatory mediators content was quantified in parallel. Several divergently composed microbiome groups were identified and characterized, the majority of patients displayed one dominant bacterial species, whereas others had a more diverse microbiome. The analysis of systemic immune biomarkers revealed two distinct inflammatory response groups, i.e., low and high response groups, each associated with a specific array of clinical symptoms, microbial composition, and diversity. Moreover, we have identified some microbiome compositions associated with high inflammatory response, i.e., high levels of pro- and anti-inflammatory cytokines, whereas other microbiomes were in correlation with low inflammatory responses. Although bronchiectasis pathogenetic mechanisms remain to be elucidated, it is clear that addressing microbiome composition in the airways is a valuable resource not only for diagnosis but also for personalized disease management. IMPORTANCE: The population of microorganisms on/in the human body resides in distinct local microbiomes, including the respiratory microbiome. It remains unclear what defines a healthy and a diseased respiratory microbiome. We investigated the respiratory microbiome in chronic pulmonary infectious disease, i.e., bronchiectasis, and researched correlations between microbiome composition, systemic inflammatory biomarkers, and disease characteristics. The bronchoalveolar microbiome of 47 patients was sequenced, and their serum inflammatory mediators were quantified. The microbiomes were grouped based on their content and diversity. In addition, patients were also grouped into low- and high-response groups according to their inflammatory biomarkers’ levels. Certain microbiome compositions, mainly single-species dominated, were associated with high levels of inflammatory cytokines, whereas others correlated with low inflammatory response and remained diverse. We conclude that respiratory microbiome composition is a valuable resource for the diagnostics and personalized management of bronchiectasis, which may include preserving microbiome diversity and introducing possible probiotics.